Weighted Average Number of Shares Outstanding, Basic of CervoMed Inc. from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CervoMed Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • CervoMed Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 9,041,760, a 12% increase year-over-year.
  • CervoMed Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 9,041,760, a 12% increase from 2024.
  • CervoMed Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 8,073,155, a 203% increase from 2023.
  • CervoMed Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2,661,416, a 414% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

CervoMed Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 9,041,760 +968,605 +12% 01 Oct 2025 31 Dec 2025 10-K 13 Mar 2026 2025 FY
Q3 2025 9,252,719 +549,955 +6.3% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 8,950,521 +247,757 +2.8% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 8,702,719 +2,532,218 +41% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 8,073,155 +5,411,739 +203% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2026 2025 FY
Q3 2024 8,702,764 +5,394,462 +163% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 8,702,764 +8,184,624 +1580% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 6,170,501 +5,652,361 +1091% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 2,661,416 +2,143,276 +414% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 3,308,302 +2,790,162 +538% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 518,140 -1,520,587 -75% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 518,140 -1,520,183 -75% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 518,140 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 518,140 -1,519,838 -75% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 2,038,727 +749 +0.04% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 2,038,323 +388,354 +24% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 2,037,978 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 2,037,978 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 1,649,969 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2018 50,572,001 +36,634,132 +263% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 50,546,021 +39,717,958 +367% 01 Apr 2018 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q3 2017 13,937,869 +3,603,971 +35% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 10,828,063 +564,360 +5.5% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2
Q3 2016 10,333,898 -8,281,070 -44% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 10,263,703 -8,351,265 -45% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q4 2015 18,614,968 +4,315,495 +30% 01 Oct 2015 31 Dec 2015 10-K 25 Mar 2016 2015 FY
Q3 2015 18,614,968 -56,153 -0.3% 01 Jul 2015 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 18,614,968 +5,747,123 +45% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 18,614,968 +12,680,494 +214% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015 2015 FY
Q4 2014 14,299,473 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 18,671,121 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 12,867,845 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 5,934,474 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 FY
Q3 2012 89,748,496 +12,213,233 +16% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q2 2012 88,182,285 +17,020,583 +24% 01 Apr 2012 30 Jun 2012 10-Q/A 07 Sep 2012 2012 Q2
Q3 2011 77,535,263 +15,013,262 +24% 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2012 Q3
Q2 2011 71,161,702 +10,393,691 +17% 01 Apr 2011 30 Jun 2011 10-Q/A 07 Sep 2012 2012 Q2
Q3 2010 62,522,001 01 Jul 2010 30 Sep 2010 10-Q 21 Nov 2011 2011 Q3
Q2 2010 60,768,011 01 Apr 2010 30 Jun 2010 10-Q 16 Aug 2011 2011 Q2

CervoMed Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 9,041,760 +968,605 +12% 01 Jan 2025 31 Dec 2025 10-K 13 Mar 2026 2025 FY
2024 8,073,155 +5,411,739 +203% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2026 2025 FY
2023 2,661,416 +2,143,276 +414% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 518,140 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2018 3,242,301 +2,414,726 +292% 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2019 2018 FY
2017 827,575 -9,405,216 -92% 01 Jan 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
2016 10,232,791 -8,382,177 -45% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 18,614,968 +4,315,495 +30% 01 Jan 2015 31 Dec 2015 10-K 25 Mar 2016 2015 FY
2014 14,299,473 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.